Murielle Foist
About Murielle Foist
Murielle Foist is the Market Access Director France BeLux at BeiGene, with extensive experience in market access, public affairs, and health economics.
Current Position at BeiGene
Murielle Foist is the Market Access Director for France BeLux at BeiGene. She started this role in March 2023 and operates from Ville de Paris, Île-de-France, France, working remotely. Her responsibilities involve overseeing market access strategies for the biotechnology company in these regions, ensuring that BeiGene's therapies reach patients effectively.
Previous Roles at LEO Pharma France
Murielle Foist has a significant background in market access. She worked at LEO Pharma France for seven years, holding positions as Market Access Manager from 2016 to 2019 and later as Market Access and Public Affairs Senior Manager from 2019 to 2023. During her time at LEO Pharma, she developed and executed market access strategies and established valuable public affairs initiatives in France.
Experience at KAMEDIS Conseils
Murielle spent a total of six years at KAMEDIS Conseils, serving initially as a Pricing & Market Access Consultant from 2010 to 2015 and later as PMA & HEOR Lead from 2015 to 2016. Her work focused on the establishment and execution of pricing, market access strategies, and health economics and outcomes research.
Early Career in Consulting and Health Economics
Before her roles at KAMEDIS Conseils, Murielle gained diverse experience as a Consultant at Bionest Partners from 2006 to 2009 and worked for Abbott Vascular in Pricing & Reimbursement/Health Economics for five months in 2010. These roles equipped her with valuable insights into consulting and the financial aspects of healthcare product management.
Educational Background
Murielle Foist has a robust educational foundation in public health and health economics. She studied at the University of Oxford and completed her HTA/HEOR program in 2011. Additionally, she achieved a Master’s degree in Public Health from Paris-Sud University (Paris XI) in 2010. Her education has underpinned her extensive career in market access and health economics.